Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncotarget ; 6(25): 21704-17, 2015 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-26023734

RESUMO

In human breast cancer, estrogen receptor-α (ERα) suppresses epithelial-mesenchymal transition (EMT) and stemness, two crucial parameters for tumor metastasis; however, the underlying mechanism by which ERα regulates these two processes remains largely unknown. Bmi1, the polycomb group protein B lymphoma Mo-MLV insertion region 1 homolog, regulates EMT transition, maintains the self-renewal capacity of stem cells, and is frequently overexpressed in human cancers. In the present study, ERα upregulated the expression of the epithelial marker, E-cadherin, in breast cancer cells through the transcriptional down-regulation of Bmi1. Furthermore, ERα overexpression suppressed the migration, invasion, and EMT of breast cancer cells. Notably, overexpression of ERα significantly decreased the CD44high/CD24low cell population and inhibited the capacity for mammosphere formation in ERα-negative breast cancer cells. In addition, overexpression of Bmi1 attenuated the ERα-mediated suppression of EMT and cell stemness. Immunohistochemistry revealed an inverse association of ERα and Bmi1 expression in human breast cancer tissue. Taken together, our findings suggest that ERα inhibits EMT and stemness through the downregulation of Bmi1.


Assuntos
Neoplasias da Mama/metabolismo , Transição Epitelial-Mesenquimal , Receptor alfa de Estrogênio/metabolismo , Regulação Neoplásica da Expressão Gênica , Complexo Repressor Polycomb 1/metabolismo , Animais , Antígeno CD24/metabolismo , Caderinas/metabolismo , Movimento Celular , Estrogênios/metabolismo , Feminino , Humanos , Receptores de Hialuronatos/metabolismo , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Invasividade Neoplásica , Metástase Neoplásica , Complexo Repressor Polycomb 1/antagonistas & inibidores , Regiões Promotoras Genéticas , Ligação Proteica , Transdução de Sinais , Células-Tronco/citologia , Cicatrização
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...